Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)

Market Cap	9.30B +35.0%
Revenue (ttm)	1.53B -1.4%
Net Income	429.67M +46.4%
EPS	0.34 +47.7%
Shares Out	1.25B
PE Ratio	21.98
Forward PE	20.67
Dividend	0.12 (1.58%)
Ex-Dividend Date	May 29, 2025

Volume	10,742,301
Average Volume	11,706,591
Open	7.55
Previous Close	7.58
Day's Range	7.43 - 7.59
52-Week Range	5.38 - 12.75
Beta	0.20
RSI	38.92
Earnings Date	Apr 24, 2026

About SHE:002550

Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China. The company offers heparin sodium, heparin calcium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, pancreatin, heparinoid API, kallidinogenase, and asparaginase. It also provides low molecular weight heparin, compound digestive enzyme preparations, and health products. In addition, the company exports its products. The company was founded in 1971 and is headquartered in Changzhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1971
• Employees: 979
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002550

Financial Performance

In 2024, SHE:002550's revenue was 1.53 billion, a decrease of -15.88% compared to the previous year's 1.81 billion. Earnings were 356.03 million, an increase of 95.77%.